Quercetin downregulates the expression of IL15 in cancer cells through DNA methylation

M Zhang1, A Lu, H Wang

  • 1Shanghai Key Laboratory of Plant Functional Genomics and Resources, Shanghai Chenshan Botanical Garden, Shanghai, China. hxwang@cemps.ac.cn.

Abstract

Insights

Quercetin inhibits cancer cell proliferation by downregulating Interleukin-15 (IL15) expression. This effect is mediated by increased methylation of the IL15 promoter region, impacting cellular immunity.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cellular immunity plays a crucial role in cancer surveillance.
  • Interleukin-15 (IL15) is a key cytokine involved in immune responses against cancer.
  • Quercetin is a natural compound with potential anti-cancer properties.

Purpose of the Study:

  • To investigate the impact of quercetin on cellular immunity, specifically IL15 expression, in cancer cells.
  • To elucidate the molecular mechanism by which quercetin affects IL15 expression.
  • To determine if quercetin influences the methylation status of the IL15 promoter.

Main Methods:

  • In vitro culture of HeLa and A549 cancer cell lines.
  • Treatment with varying concentrations of quercetin.
  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to measure IL15 and DNA methyltransferase (DNMTs) transcript levels.
  • Bisulfite sequencing to analyze IL15 promoter methylation.

Main Results:

  • Quercetin treatment led to significant downregulation of IL15 expression in both cell lines.
  • IL15 promoter methylation levels increased approximately twofold in HeLa cells and threefold in A549 cells post-quercetin treatment.
  • A correlation was observed between quercetin concentration and increased IL15 promoter methylation.

Conclusions:

  • Quercetin exhibits anti-proliferative effects on cancer cells.
  • Quercetin downregulates IL15 expression.
  • The downregulation of IL15 by quercetin is mediated through epigenetic modification, specifically by increasing the methylation of the IL15 promoter.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K